Outsourced Lab Networks: Oversight Models That Work in Practice Outsourced Lab Networks: Oversight Models That Work in Practice In the world of pharmaceutical and biotech development, the integration of Regulatory Affairs, Good Laboratory Practice (GLP), and compliance with quality systems is not just an operational necessity; it’s a regulatory mandate. This article explores the intricacies of oversight models for outsourced lab networks, focusing on regulatory affairs and compliance in the context of drug submissions and lifecycle management. Regulatory Affairs Context Regulatory Affairs serves as a bridge between the scientific community and regulatory bodies such as the FDA, EMA, and MHRA….

How Lab Change Control and Validation Feed Regulatory Filings How Lab Change Control and Validation Feed Regulatory Filings Context In the highly regulated pharmaceutical and biotechnology sectors, ensuring compliance with Good Laboratory Practice (GLP) and maintaining robust quality systems are critical aspects of Regulatory Affairs (RA). Effective integration of laboratory change control and validation processes significantly impacts regulatory submissions and overall product lifecycle management. Understanding the intricate connection between laboratory practices and regulatory requirements is essential for Regulatory Affairs professionals, especially those involved in pharmacovigilance and ensuring adherence to GxP guidelines. Legal/Regulatory Basis The foundation of laboratory compliance and regulatory…

Dealing with Historical Data Problems When Filing Variations or New Claims Dealing with Historical Data Problems When Filing Variations or New Claims In the highly regulated pharmaceutical and biotech sectors, the integration of good practices and quality systems is of utmost importance, especially when it comes to the submission of variations and new claims. This article aims to provide a detailed manual for regulatory affairs professionals navigating the challenges of historical data problems when filing with global regulatory authorities. Regulatory Affairs Context Regulatory Affairs (RA) serves as the bridge between the pharmaceutical industry and regulatory authorities such as the FDA…

Integrating GLP Study Reports into CTD and eCTD Modules Integrating GLP Study Reports into CTD and eCTD Modules The integration of Good Laboratory Practice (GLP) study reports into Common Technical Document (CTD) and electronic CTD (eCTD) modules is a critical component of regulatory submissions in the pharmaceutical and biotechnology industries. This article serves as a comprehensive manual for Regulatory Affairs (RA) professionals, especially those involved in Chemistry, Manufacturing, and Controls (CMC) and labeling, as it outlines the relevant regulations, guidelines, agency expectations, documentation requirements, review flows, and common deficiencies associated with this integration. By adhering to these structured approaches, RA…

Designing KPI Dashboards for Lab Compliance and Performance Designing KPI Dashboards for Lab Compliance and Performance In the realm of pharmaceutical and biotechnology sectors, regulatory compliance is paramount. Laboratories must adhere to Good Laboratory Practice (GLP) and ensure compliance through stringent adherence to regulatory guidelines. This article serves as a regulatory explainer manual on designing Key Performance Indicator (KPI) dashboards for lab compliance and performance, detailing the regulatory context, expectations, documentation requirements, and common deficiencies in laboratory compliance reporting. Regulatory Context Regulatory Affairs (RA) operates at the intersection of compliance, quality, and operational excellence within pharmaceutical and biotech companies. The…

Training Lab and RA Teams on Each Other’s Expectations and Language Training Lab and RA Teams on Each Other’s Expectations and Language Context In the highly regulated pharmaceutical and biotech sectors, the integration of Good Laboratory Practice (GLP), Analytical Lab Compliance, and Regulatory Affairs (RA) is crucial for ensuring that products are safe, effective, and of high quality. This integration is particularly relevant in the context of pharmacovigilance systems, which focus on monitoring the safety profile of marketed products throughout their lifecycle. Effective collaboration between QA, QC, and regulatory teams ensures not only compliance but also improves operational efficiency and…

Using Investigations and CAPA from Labs to Strengthen Dossiers Using Investigations and CAPA from Labs to Strengthen Dossiers Regulatory compliance is essential for pharmaceutical and biotech firms navigating the complex landscape of global health regulations. This article focuses on the integration of Good Laboratory Practice (GLP) and analytical lab compliance with regulatory affairs, specifically how investigations and Corrective and Preventive Actions (CAPA) can bolster submission dossiers. Understanding the regulatory framework and operational practices ensures that organizations not only meet the stringent expectations outlined by agencies such as the FDA, EMA, and MHRA but also strengthen the integrity of their submissions….

Templates for Lab Quality Summaries in Regulatory Submissions Templates for Lab Quality Summaries in Regulatory Submissions In the increasingly regulated landscape of pharmaceuticals and biotechnology, the integration of good practice (GxP) quality systems with regulatory affairs is paramount. This applies especially to laboratories handling analytical data that support submission dossiers. The primary aim is to ensure compliance with the rigorous standards imposed by regulatory authorities such as the FDA, EMA, and MHRA. This article provides a comprehensive guide to creating lab quality summaries, detailing the relevant regulations, agency expectations, and common deficiencies encountered during submissions. Regulatory Affairs Context In the…

Preparing for Lab and GLP Inspections Linked to Key Filings Preparing for Lab and GLP Inspections Linked to Key Filings Context In the pharmaceutical and biotechnology industries, Regulatory Affairs (RA) plays a critical role in ensuring compliance with regulatory frameworks and quality systems. As part of the overall lifecycle management of pharmaceutical products, RA must coordinate with various functional areas such as Chemistry, Manufacturing, and Controls (CMC), Clinical, Pharmacovigilance (PV), Quality Assurance (QA), and Commercial teams. This collaborative approach ensures that all submissions to regulatory authorities like the FDA, EMA, and MHRA are robust and compliant, particularly when preparing for…

Future Trends: Automation, Digital Labs and Their Regulatory Implications Future Trends: Automation, Digital Labs and Their Regulatory Implications The landscape of pharmaceutical and biotech manufacturing is evolving rapidly, driven by advancements in technology such as automation and the establishment of digital laboratories. Understanding the regulatory implications of these trends is essential for Regulatory Affairs (RA) professionals, particularly in the context of compliance with Good Laboratory Practice (GLP) and associated GxP quality systems. This article serves as a comprehensive guide for regulatory affairs teams in the US, UK, and EU, examining the regulations, guidelines, and agency expectations related to the integration…